EWM
TEVA icon

Edge Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Edge Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,150
Closed -$14K – 614
2020
Q2 		$14K Hold
1,150
– – ﹤0.01% 422
2020
Q1 		$10K Buy
1,150
+900
+360% +$9.22K ﹤0.01% 401
2019
Q4 		$2K Hold
250
– – ﹤0.01% 540
2019
Q3 		$1K Hold
250
– – ﹤0.01% 569
2019
Q2 		$2K Hold
250
– – ﹤0.01% 539
2019
Q1 		$4K Hold
250
– – ﹤0.01% 488
2018
Q4 		$4K Sell
250
-200
-44% -$4.1K ﹤0.01% 496
2018
Q3 		$10K Sell
450
-150
-25% -$3.48K ﹤0.01% 438
2018
Q2 		$15K Hold
600
– – ﹤0.01% 379
2018
Q1 		$10K Hold
600
– – ﹤0.01% 388
2017
Q4 		$11K Sell
600
-35
-6% -$527 ﹤0.01% 373
2017
Q3 		$11K Sell
635
-200
-24% -$4.5K ﹤0.01% 358
2017
Q2 		$27K Sell
835
-80
-9% -$2.48K 0.01% 274
2017
Q1 		$29K Buy
915
+400
+78% +$13.7K 0.01% 254
2016
Q4 		$19K Sell
515
-8,193
-94% -$327K 0.01% 281
2016
Q3 		$401K Buy
8,708
+2,120
+32% +$111K 0.17% 78
2016
Q2 		$329K Buy
6,588
+6,360
+2,789% +$339K 0.14% 86
2016
Q1 		$12K Buy
+228
New +$13.4K 0.01% 272
2013
Q3 		– Sell
-90,579
Closed -$3.55M – 360
2013
Q2 		$3.55M Buy
+90,579
New +$3.53M 2.37% 19

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Edge Wealth Management's TEVA Position: Q3 2020 in Review

Edge Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 1,150 shares — an estimated $14K sold.

Edge Wealth Management first reported a position in TEVA in Q2 2013 and held it in 19 quarters. The position peaked at $3.55M in Q2 2013. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Edge Wealth Management reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Edge Wealth Management sold 1,150 Teva Pharmaceuticals shares in Q3 2020, an estimated $14K.
  • Edge Wealth Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • Edge Wealth Management's Teva Pharmaceuticals position peaked at $3.55M in Q2 2013.
  • 443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Edge Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.